Back to Search
Start Over
Cost-Effectiveness of Escalating to Natalizumab or Switching Among Immunomodulators In Relapsing-Remitting Multiple Sclerosis In Italy.
- Source :
-
Value in Health . Nov2015, Vol. 18 Issue 7, pA695-A695. 1p. - Publication Year :
- 2015
Details
- Language :
- English
- ISSN :
- 10983015
- Volume :
- 18
- Issue :
- 7
- Database :
- Academic Search Index
- Journal :
- Value in Health
- Publication Type :
- Academic Journal
- Accession number :
- 110432171
- Full Text :
- https://doi.org/10.1016/j.jval.2015.09.2588